Immunocore Alternatives & Competitors
12 companies similar to Immunocore — Science to Transform Lives
Companies similar to Immunocore
Tmunity Therapeutics
Pioneering the future of immunotherapy through innovative T cell engineering to tackle a d...
Genmab
Differentiated human antibody therapeutics for the treatment of cancer
Denmark
Sodertalje, Sweden
Orca Bio
Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.
Menlo Park, United States
Rival Readout
Competing with Immunocore? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Cambridge, United States
Zenas BioPharma
Enabling patients with autoimmune diseases to reimagine life
Waltham, United States
Connect Biopharma
Global Clinical Stage Company Connecting Patients with Innovation for Life
San Diego, United States
Zai Lab
Delivering innovative, transformational outcomes to patients around the world
China
Xencor
Proteins by Design
Pasadena, United States
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Santa Monica, United Stat...
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
London, United Kingdom
Seismic Therapeutic
The Machine Learning Immunology Company
Watertown, United States
About Immunocore
Immunocore, founded in 2008 and headquartered in the United Kingdom, is a prominent player in the Biotechnology, Health Care, and Pharmaceutical industries. The company's slogan, "Science to Transform Lives," encapsulates its mission to develop groundbreaking T cell receptor (TCR) biological therapies. These therapies...
Development of TCR therapies, Clinical trials management, Research in immunotherapy, Therapeutic pipeline development
Patients with cancer, Patients with infectious diseases, Patients with autoimmune diseases, Healthcare professionals
T Cell Receptor, Immunotherapy, Cancer Therapy, Oncology, Metastatic Melanoma, Infectious Diseases, Autoimmune Diseases, Bispecific Immunotherapies, TCR Technology Platform, Antibody Fragment Engineering, Clinical Trials, Drug Discovery, Biological Therapies, Unmet Patient Needs
B2B, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Immunocore: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Immunocore on 22 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 25 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
